🇺🇸 US Stock Screener ← Switch market ⚡ HerAI

Modular Medical, Inc. MODD PHARMA

Healthcare · Medical Devices · United States
https://www.modularmedical.com
Company Profile ↓
$2.82
-87.09% 1Y
Mkt Cap$22.99M
P/E-0.29
P/B1.14
52W High$22.83
52W Low$1.87
Book Value$1.93
EPS (TTM)$-9.85

Company Overview

Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It offers Pivot product, a tubeless insulin delivery system that integrates the set into a true tubeless patch. Modular Medical, Inc. is headquartered in San Diego, California.

Growth & Price Performance

Stock Price Performance

1 Year:-87.09%
6 Months:-52.53%
3 Months:-41.98%
1 Month:+28.18%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 5% of range
$1.87 $22.83
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)44.44 · Neutral
Price Performance
1M+28.18%
3M-41.98%
6M-52.53%
1Y-87.09%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading 87.7% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.29
Industry PE
24.83
Forward P/E
-5.53
PEG Ratio
-
Book Value
$1.93
Price to Book
1.14
P/S
-
EV/EBITDA
-0.54
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-
Profit 5Y
-
Revenue (YoY)
-
Earnings (YoY)
-

Profitability & Returns

ROCE
-
ROE
-
ROA
-
Profit Margin
0.00%
Op Margin
0.00%
Gross Margin
0.00%
EPS (Latest Qtr)
$-0.11
EPS (TTM)
$-9.85

Balance Sheet & Liquidity

Debt/Equity
2.58
Quick Ratio
2.79
Current Ratio
3.25
Debt
$278.00K
Total Assets
$14.83M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
1.69%
Chg in Prom Hold
-0.86%
FII / Inst Holding
28.08%
Chg in FII Hold
-3.38%

Financial Snapshot

Enterprise Value
$22.99M
Total Revenue (TTM)
$0
EBITDA
$-25.53M
Free Cash Flow
$-17.97M
Operating Cash Flow
$-24.35M
Shares Outstanding
8.15M
Gross Margin
0.00%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 MODD Modular Medical, Inc. PHARMA 2.82 -0.29 $22.99M 0.00% - - - -
2 LLY Eli Lilly and Company SPXR3KPHARMA 1,123.91 37.80 $1.00T 0.60% - 102.29% 7.20% 11.41%
3 JNJ Johnson & Johnson SPXR3KPHARMA 269.12 31.22 $648.55B 1.98% 14.88% 25.74% 2.43% 4.76%
4 ABBV AbbVie Inc. SPXR3KPHARMA 248.78 70.48 $439.62B 2.78% 10.47% -129.24% 1.75% -29.06%
5 MRK Merck & Co., Inc. SPXR3KPHARMA 148.46 118.77 $366.28B 2.31% - 6.96% 5.64% 10.01%
6 UNH UnitedHealth Group Incorporated SPXR3KPHARMA 400.84 25.74 $359.79B 2.47% 9.74% 14.15% 10.40% 5.43%
7 NVS Novartis AG PHARMA 137.70 20.80 $261.73B 3.36% 21.09% 30.35% 9.25% 26.22%
8 AZN AstraZeneca PLC NDXPHARMA 160.04 23.99 $248.20B 2.00% 15.97% 21.96% 9.82% 45.96%
9 TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA 603.02 32.49 $222.97B 0.29% 8.14% 13.51% 8.81% 12.95%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2013Sep 2013Dec 2013Mar 2014Sep 2014Dec 2014Mar 2015Sep 2015Dec 2015Mar 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Jun 2018Sep 2018Dec 2018Jun 2019Sep 2019Dec 2019Jun 2020Sep 2020Dec 2020Jun 2021Sep 2021Dec 2021Jun 2022Sep 2022Dec 2022Jun 2023Sep 2023Dec 2023Jun 2024Sep 2024Dec 2024Jun 2025Sep 2025Dec 2025
Revenue 0000000000000000000---------------------
Gross Profit 0000000000000--0--0---------------------
Operating Income -2.05K-4.41K-2.48K-2.15K-4.52K-3.86K-4.12K-6.85K-2.42K-2.14K-1.71K-5.81K-2.19K-37.48K-175.99K-260.86K-255.19K-549.00K-750.56K-1.14M-1.16M-1.14M-1.87M-1.86M-1.87M-3.37M-3.69M-3.83M-3.50M-3.45M-3.36M-3.75M-4.19M-5.27M-4.22M-5.00M-4.85M-6.80M-7.83M-7.24M
Net Income -4.56K-7.21K-5.46K-5.20K-7.86K-7.53K-7.96K-11.03K-6.86K-6.72K-1.47K-6.43K-7.50K-38.74K-176.00K-258.77K-249.57K-543.77K-739.21K-1.12M-1.15M-1.13M-1.87M-1.86M-1.87M-4.84M-4.38M-4.84M-3.50M-3.45M-3.36M-3.74M-4.18M-5.27M-4.14M-4.96M-4.80M-6.70M-7.79M-7.36M
Diluted EPS -----------------------------0.33-0.28-0.27-0.22-0.19-0.23-0.12-0.14-0.13-0.12-0.14-0.11
R&D Expense -----------0-083.41K171.04K135.79K367.55K504.79K703.78K633.24K608.02K970.82K1.09M1.09M1.79M2.11M1.85M2.22M2.38M2.20M2.77M3.16M3.84M3.21M3.70M3.85M5.13M5.59M5.41M

Profit & Loss (Annual)

Figures in USD.

Metric Jun 2000Jun 2001Jun 2002Jun 2003Jun 2004Jun 2005Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Mar 2017Jun 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -----------000000000--------
Gross Profit -----------000000-----------
Operating Income ------------9.17K-9.51K-10.92K-10.77K-16.11K-13.16K-29.42K-91.05K-666.16K-2.58M-5.35M-7.34M-14.93M-13.88M-17.53M-19.05M-27.56M
Net Income -6.83K-32.30K-26.64K-3.94K-6.21K-14.29K-8.91K-6.48K-6.72K-9.40K-7.67K-9.17K-17.49K-20.79K-22.79K-30.99K-31.08K-29.26K-106.56K-659.25K-2.54M-5.32M-7.38M-18.63M-13.88M-17.47M-18.82M-28.24M
Diluted EPS ------------------------2.74-1.15-0.78-15.26-12.36
R&D Expense -----------------0-332.64K1.88M3.03M4.08M7.73M9.06M12.88M14.70M19.97M

Balance Sheet (Annual)

Figures in USD.

Metric Oct 1998Jun 1999Jun 2000Jun 2001Jun 2002Jun 2003Jun 2004Jun 2005Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016Jun 2016Mar 2017Jun 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -------------00002.50K-0392.31K1.37M4.33M6.65M3.86M2.25M9.85M7.25M13.81M18.73M14.83M
Total Equity 023.79K16.97K25.81K-822-4.77K-10.97K-23.76K-31.17K-37.65K-44.37K-53.77K-61.44K-70.61K-88.10K-108.89K-131.69K-162.68K379.84K-193.76K362.63K1.30M4.32M6.47M2.88M-1.28M8.84M5.08M11.54M17.08M12.96M
Cash & Equivalents ---------------000389.62K0392.01K1.37M4.30M6.55M3.12M1.47M9.08M3.80M9.23M13.10M6.94M
Total Liabilities -------------70.61K88.10K108.89K131.69K165.18K-193.76K29.68K-15.47K178.73K980.13K3.52M1.01M2.17M2.27M1.66M1.87M
Current Liabilities -------------70.61K88.10K108.89K131.69K165.18K-193.76K29.68K74.42K15.47K178.93K661.39K3.30M969.70K979.00K1.46M1.26M1.87M

Cash Flows (Annual)

Figures in USD.

Metric Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Mar 2017Jun 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 00000-10.66K-21.14K-94.81K-791.13K-1.81M-4.09M-5.91M-10.26M-11.01M-13.95M-15.72M-23.75M
Investing Cash Flow 00000000-15.33K-77.12K-260.79K-109.67K-54.76K-1.64M-1.70M-2.49M-3.93M
Financing Cash Flow 0000010.66K23.52K1.47M4.71M4.14M923.99K4.36M17.92M7.37M21.09M22.08M21.53M
Capital Expenditure -0-0-0-0---0--15.12K-77.12K-260.79K-109.67K-54.76K-1.64M-1.70M-2.49M-3.93M
Free Cash Flow 0000---21.14K--806.25K-1.89M-4.36M-6.02M-10.31M-12.65M-15.65M-18.21M-27.68M
Share Buybacks -----0187.95K14.10K0--------

Ratios (Annual)

Figures in %.

Metric Jun 2000Jun 2001Jun 2002Jun 2003Jun 2004Jun 2005Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Mar 2017Jun 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % ----------------------------
Operating Margin % ----------------------------
Net Margin % ----------------------------
ROE % -40.2%-125.1%3,240.3%82.8%56.6%60.1%28.6%17.2%15.1%17.5%12.5%13.0%19.9%19.1%17.3%19.1%16.0%-8.1%-8.2%-15.3%-39.2%-184.9%578.6%-210.8%-273.4%-151.5%-110.2%-217.9%
ROCE % -----------13.0%10.8%10.0%8.2%9.9%6.8%-8.1%-7.0%-15.4%-39.8%-167.3%699.5%-168.2%-221.5%-141.9%-109.0%-212.7%

Shareholding Pattern

Insiders
1.69%
Institutions
28.08%
Public Float
28.56%

Top Institutional Holders

#Holder% HeldSharesValue
1 AWM Investment Company, Inc. 5.41% 441.10K $970.41K
2 Solas Capital Management, LLC 5.37% 438.10K $963.81K
3 Bleichroeder LP 4.13% 336.99K $741.37K
4 683 Capital Management LLC 1.59% 130.00K $286.00K
5 Vanguard Capital Management LLC 1.27% 103.18K $227.00K
6 Bard Associates Inc. 1.25% 101.74K $223.84K
7 Northern Trust Corporation 0.76% 62.33K $137.13K
8 Geode Capital Management, LLC 0.65% 52.65K $115.82K
9 Sio Capital Management, LLC 0.32% 26.19K $57.62K
10 HighTower Advisors, LLC 0.24% 19.82K $43.62K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for MODD

Google News Fri, 04 Sep 2026

A national U.S. health benefits manager now makes Modular Medical’s tubeless insulin pump available - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOX1IydFpSa094dURNbEJFZmx5ODNydFViYnloUFNVRFVRWlRRVW8xTy1UcG5jWElKc3o0NXdpaFdZVlNOcjI2MzFhVjJYZEc2UENHN0dBY2tRalJudkxQVl92cTM0TXVEaXg2aTN0SGRTWU9EOFpkU1dsb2VSU1hXLXJFb2JtMkFRblFvem…

Google News ue, 08 Sep 2026

Modular Medical Signs Contract with National PBM for Pivot System - Intellectia AI

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPRDg2cF83bThUUFRxQVJKNTFTaUcxZGFjN2ZKNlpPOWJSeWpNcGFsWXE5NHhxSVVuRkk0NVhGSi1GeHNJS05tM2tPcmZ0ODJQZ290VmVEaHRyNWgtZEJXVl9VM211d1VWSWVXWV9Qc3lNRHFDYk95N0xhTE9OWEQtVzdqU3pUTEFCM2JmWk…

Google News hu, 03 Sep 2026

EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades - tradingview.com

<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxNLTlZTzhGeEg0cVpXeFltYUdyTklwWEl3VFpqUlZ6NG9qRFg5T1RvR3YzMndPSW9vMU83Q25MYmxrb3M2NEhGX1NfNEFLbEFiNVE5aEZFaXBabkltQk0ydWdVUDJ2RTRnQ0xXM0wyZTdwdlFkSEhVRE12RkxSaWNWQTlFY2RYMmJDV3BPbk…

Google News Fri, 31 Jul 2026

Top movers in Friday's after hours session - ChartMill

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPalh2MkRRQ0ROV0xRT2c2OGwtMDBOaGdUQXMzdlhUZURTU3M2NDVwbmlyNkhYZThNbTRjdG5sTjFZOFUxenNjdmxfUDZIWFpWREFDOFRScnNZWXdUR2l2MTRqdUdyb2JoeHlWSVRDMmJiSEM1U0laVmxpSlVfRWVpLXU0QXNDTVBFVFpRWk…

Google News ue, 26 May 2026

MODD - Finviz

<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE9Jcnh0UVMwNjE5clFteWg2OTdaMXUwTTI4VF9fYUZsTWlPMXF1QThrUjZpMXp4NWg3LXpPeExKb0JoRGxWdmc?oc=5" target="_blank">MODD</a>&nbsp;&nbsp;<font color="#6f6f6f">Finviz</font>…

Google News hu, 03 Sep 2026

The FDA cleared new controls for a tubeless insulin pump. Users can customize each button push. - Stock Titan

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxObXhLMmc1SkVUbTY4c1FxcTc3dkIydFlqMlQyMmpuTUtZWUZVNngzbWY0RzFXQ3VRV205Q3JteHVPLXZCOVJIZUROeGZVVzJ5NXd1NENqbVNlM2lxM1lWMDNYbnoxNWRyWks2cnhSQTlCdUdoV1g0aU8yaVEyZjZSY1hNQ0hPenNzUzZ1Zn…

MODD — Frequently Asked Questions

What is the current share price of Modular Medical, Inc. (MODD)?

As of 2026-09-19 21:16 PDT, Modular Medical, Inc. (MODD) trades at $2.82 on NasdaqCM. Its 52-week range is $1.87 to $22.83.

What is the market capitalisation of MODD?

Modular Medical, Inc. (MODD) has a market capitalisation of $22.99M on NasdaqCM.

What is the P/E ratio of MODD?

MODD trades at a trailing price-to-earnings (P/E) ratio of -0.29. The industry average P/E is 24.83. Its price-to-book (P/B) ratio is 1.14.

Is MODD a good stock to buy?

This page provides a data-driven analysis of Modular Medical, Inc. (MODD), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space